Human-Computer Interaction Resource Network
| ZymoGenetics | |
| ZymoGenetics targets promising protein therapies. | |
| Keywords : ZymoGenetics, Zymo, Biotechnology, Protein, Antibody, Antibodies, Bispecific, Bi-specific, Cytokine, Receptor, RECOTHROM, Thrombin, Coagulation, IL-21, IL21, Cancer, Oncology, PEG Interferon lambda, IL-29, IL29, Hepatitis C, HCV, Autoimmune, Autoimmunity, |
| Last Update : | 03/December/2011 |
| Google PR : | 5 |
| Indexed pages : | 8 |
| Internal links : | 3 |
| External links : | 4 |
| Archive : | Check how did the site look in the past? |
| Site IP address : | 208.109.74.61 |
| Server type : | Apache |
| DNS 1 : | ns1.xo.com |
| DNS 2 : | ns2.xo.com |
| DNS 3 : | ns3.xo.com |
| DNS 4 : | ib.zgi.com |
| MX Domain 1 : | zymogenetics.com.s5b1.psmtp.com |
| MX Domain 2 : | zymogenetics.com.s5b2.psmtp.com |
| MX Domain 3 : | zymogenetics.com.s5a1.psmtp.com |
| MX Domain 4 : | zymogenetics.com.s5a2.psmtp.com |
| Alexa rank : | 9,179,790 |
| Description : |
| zymogenetics | 46.67% |
| zymogenetics inc. | 18.41% |
| zymogenetics inc | 14.75% |
| zymogenetics inc. wa 98102 | 3.19% |
| seattle fremont biotech | 3.08% |
| yzymo | 2.84% |
| zg-.com | 2.71% |
| dendreon | 2.43% |
| dendreon corporation | 2.43% |
| seattle genetics inc | 1.40% |
| Quantcast rank : | 0 | Average US daily traffic : |
| Compete rank : | 0 |
| Average daily unique visitors : | 0 |
| MyWot rank : | 0 |
| Trustworthiness : | 76 |
| Vendor reliability : | 0 |
| Privacy : | 0 |
| Child safety : | 0 |
| xencor.com | voyagerpharma.com | trophogen.com | rib-x.com | praecis.com |
| curis.com | biosphings.com | biomep.com | avigen.com | zymic.com |
| zymmetrical.com | zymnavoda.org.ua | zymmetrical.de | zymmetrical.es | zymoresearch.com |
| zymogen.net | genetics.org | plosgenetics.org | nslij-genetics.org |
|
|
|
|
|
|